Enovis ENOV
NYSE ENOV
$18.60 -0.43 (-2.26%)
As of: Sep 10, 2026 · 12:40 PM EDT

Enovis (ENOV) Cash from Investing Activities (2010 - 2026)

Enovis' (ENOV) quarterly Cash from Investing Activities came in at -$45.0 million in Q3 2026, up 9.62% year-over-year from -$41.1 million in Q3 2025, and up 15.23% quarter-over-quarter from -$53.1 million in Q2 2026.

Analysis

Enovis (ENOV) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Enovis (ENOV) has reported Cash from Investing Activities for 17 consecutive years, with -$45.0 million the latest figure, recorded in Q3 2026.

  • On a quarterly basis, Cash from Investing Activities rose 9.62% year-over-year to -$45.0 million in Q3 2026; TTM through Jul 2026 was -$167.2 million, a 26.24% increase from a year earlier, with the FY2025 full-year figure at -$179.4 million, up 81.23% from the prior year.
  • Cash from Investing Activities was -$45.0 million for Q3 2026 at Enovis, up from -$53.1 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$13.0 million in Q4 2025 and troughed at -$797.8 million in Q1 2024.
  • A 5-year average of -$91.8 million and a median of -$51.4 million in 2025 frame the typical range for Cash from Investing Activities.
  • Across the five-year window, Cash from Investing Activities slumped 2220.32% in 2024 and surged 92.41% in 2025, its largest moves.
  • Over 5 years, Cash from Investing Activities stood at -$37.1 million in 2022, then slumped by 60.14% to -$59.4 million in 2023, then advanced by 2.51% to -$57.9 million in 2024, then surged by 77.56% to -$13.0 million in 2025, then sank by 246.48% to -$45.0 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$45.0 million (Q3 2026), -$53.1 million (Q2 2026), and -$13.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 181.19 Bn 175.58 Bn 7.27 Bn -673.00 Mn
2 Intuitive Surgical 127.77 Bn 122.55 Bn 1.96 Bn -26.60 Mn
3 Medtronic 117.13 Bn 108.31 Bn 6.34 Bn -1.62 Bn
4 Stryker 104.67 Bn 101.20 Bn 4.50 Bn -639.00 Mn
5 Boston Scientific 64.48 Bn 63.94 Bn 3.85 Bn -1.96 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn -193.20 Mn
7 Alcon 33.06 Bn 31.61 Bn 1.68 Bn -222.00 Mn
8 Dexcom 32.37 Bn 30.43 Bn 830.00 Mn 329.80 Mn
9 Steris 20.76 Bn 20.28 Bn 684.20 Mn -108.50 Mn
10 Enovis 1.07 Bn 1.06 Bn 359.25 Mn -45.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 -45.01 Mn
Apr 3, 2026 -53.10 Mn
Dec 31, 2025 -12.99 Mn
Oct 3, 2025 -56.06 Mn
Jul 4, 2025 -49.80 Mn
Apr 4, 2025 -60.52 Mn
Dec 31, 2024 -57.88 Mn
Sep 27, 2024 -58.42 Mn
Jun 28, 2024 -41.33 Mn
Mar 29, 2024 -797.84 Mn
Dec 31, 2023 -59.37 Mn
Sep 29, 2023 -17.11 Mn
Jun 30, 2023 -131.60 Mn
Mar 31, 2023 -34.39 Mn
Dec 31, 2022 -37.08 Mn
Sep 30, 2022 -59.14 Mn
Jul 1, 2022 -45.01 Mn
Apr 1, 2022 -35.17 Mn
Dec 31, 2021 -26.83 Mn
Oct 1, 2021 -21.55 Mn